Rapid Read    •   7 min read

Biglaw Firms Delay Response to Milbank's Special Bonus Announcement, Leaving Associates in Limbo

WHAT'S THE STORY?

What's Happening?

Milbank recently announced special bonuses for its associates, ranging from $6,000 to $25,000 based on class year. Despite this announcement, other major law firms, collectively known as Biglaw, have not yet responded with similar bonus offerings. This delay mirrors a similar situation from the previous summer when Milbank's announcement was only matched after Cravath declared its year-end bonuses. Smaller firms like Vartabedian Hester & Haynes, Otterbourg, Bell Nunnally, and Hueston Hennigan have already awarded summer bonuses to their associates, but the larger firms remain silent. The legal community is now anticipating whether these firms will eventually match Milbank's bonuses to remain competitive in associate compensation.
AD

Why It's Important?

The delay in bonus announcements from Biglaw firms highlights the competitive nature of associate compensation in the legal industry. Bonuses are a significant part of associate remuneration, impacting job satisfaction and retention. If Biglaw firms do not match Milbank's bonuses, they risk losing talent to firms that offer more competitive compensation packages. This situation underscores the broader issue of compensation transparency and the pressure on firms to maintain parity with their peers to attract and retain top legal talent. The outcome of this waiting game could influence compensation strategies across the legal sector.

What's Next?

As the Labor Day deadline approaches, it is expected that Biglaw firms will announce their bonus plans to avoid being outpaced by competitors. Associates and industry observers are closely monitoring these developments, anticipating that firms will eventually align with Milbank's offerings. The legal community is encouraged to report any bonus announcements to keep the market informed and potentially prompt further action from other firms.

AI Generated Content

AD
More Stories You Might Enjoy